Scripps VIVO

Academic Article RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• 5-HT(1A) receptor activation: short-term effects on the mRNA expression of the 5-HT(1A) receptor and galanin in the raphe nuclei
• 5-HT(1A) receptor binding in the dorsal raphe nucleus is implicated in the anxiolytic-like effects of Cinnamomum cassia
• 5-ht(1a) receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups
• 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission
• 5-HT(2C) agonists as therapeutics for the treatment of schizophrenia
• 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
• 5-HT(7) receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
• 5-HT1A autoreceptors in the dorsal raphe nucleus convey vulnerability to compulsive cocaine seeking
• 5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology
• 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfany l-1- 4-(5-methoxy-pyrimidin-2-yl)-benzyl -1H-indol-2-yl}-2,2-dimethyl-pr opionic acid (AM679)-A potent FLAP inhibitor
• 5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103)
• 5-N,4-O-carbonyl-7,8,9-tri-O-chloroacetyl-protected sialyl donor for the stereoselective synthesis of alpha-(2-->9)-tetrasialic acid
• 5S rRNA gene transcription factor IIIA alters the helical configuration of DNA
• 6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: Optimization of the 1-position benzoyl side chain
• 6,8-di-C-glycosyl flavonoids from Dendrobium huoshanense
• 6,9-pyridazaprostacyclin and derivatives: the first "aromatic" prostacyclins
• 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2)
• 6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin Type-1 repeats by protein O-fucosyltransferases 1 and 2
• 6-Deoxyerythronolide B synthase thioesterase-catalyzed macrocyclization is highly stereoselective
• 6-endo-hydroxy-3-endo-aminomethylbicyclo[2.2.1]heptane-2-endo-carboxylic acid lactam
• 6-substituted hexamethylene amiloride (HMA) derivatives as potent and selective inhibitors of the human urokinase plasminogen activator for use in cancer
• 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience
• 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase
• 7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal Cultures
• 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1
• 7-iron ferredoxin revisited
• 7-nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat
• 8-Azaguanine reporter of purine ionization states in structured RNAs
• 8-Br-cyclic GMP mimics activation of muscarinic autoreceptor and inhibits acetylcholine release from rat hippocampal slices
• 8-epi-Salvinorin B: crystal structure and affinity at the kappa opioid receptor

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...